Assessing Risk of Death in People with Problematic Drug Use Dr Emma - - PowerPoint PPT Presentation

▶
assessing risk of death in people with problematic drug
SMART_READER_LITE
LIVE PREVIEW

Assessing Risk of Death in People with Problematic Drug Use Dr Emma - - PowerPoint PPT Presentation

Oct 12, 2023 17 likes •132 views

Assessing Risk of Death in People with Problematic Drug Use Dr Emma Fletcher , Jerusha Vithiyanandan, Dr Phyllis Easton, Dr Fiona Cowden, Dr Vered Hopkins, Superintendent John Wyllie, Professor Nick Fyfe Drug-related deaths in Scotland, 3- and

slide-1
SLIDE 1

Assessing Risk of Death in People with Problematic Drug Use

Dr Emma Fletcher, Jerusha Vithiyanandan, Dr Phyllis Easton, Dr Fiona Cowden, Dr Vered Hopkins, Superintendent John Wyllie, Professor Nick Fyfe

slide-2
SLIDE 2

Drug-related deaths in Scotland, 3- and 5-year moving averages 1996-2018

Source: National Records of Scotland. Drug-related deaths in Scotland in 2018

slide-3
SLIDE 3

Key findings in Tayside

  • Mean age 40.2 years
  • 60% deaths – people living in most deprived

areas

  • 80% recorded as having experienced at least
  • ne adverse event in life
  • 46% had been in prison or on remand at least
  • nce
slide-4
SLIDE 4

Mental health co-morbidity

38 (49%) - mental health condition at time of death Further 19 (24%) - prior mental health condition Most commonly:

  • Depression – 30 (39%)
  • Anxiety – 15 (19%)
slide-5
SLIDE 5

Morphine / Heroin Etizolam Methadone Pregabalin Diazepam Gabapentin Alprazolam Cocaine Alcohol 2016 38 21 31 12 17 13 1 1 5 2017 52 35 34 24 21 17 12 8 5 2018 48 49 38 32 22 18 10 16 11 2016 68% 38% 55% 21% 30% 23% 1.8% 1.8% 9% 2017 71% 48% 47% 33% 29% 23% 16% 11% 7% 2018 61% 63% 49% 41% 28% 23% 13% 20% 14% 10 20 30 40 50 60 Number

2016 2017 2018

Drugs referred to in death certificate

slide-6
SLIDE 6

Risk factors identified to date….

  • Male gender
  • Concurrent depression and or anxiety
  • Opioid use
  • (Barbituate use)
  • Co-morbid health conditions
  • Benzodiazepine prescription (1993-2004)
  • Shorter duration of methadone use / no OST
  • Prison liberation
slide-7
SLIDE 7

Our study…

  • Retrospective cohort study
  • Using the anonymised information from

persons known to specialist substance misuse services in Tayside on 1st Jan 2014

  • Follow-up 5 years
slide-8
SLIDE 8

Data variables include…

  • Engagement with substance misuse services
  • Living circumstances
  • Employment
  • Co-morbidities
  • Significant life events
  • Police contact – y/n and date
  • Vulnerable persons database – y/n
slide-9
SLIDE 9

Progress to date

  • First proposed to ADPs and NHS Tayside in

Spring 2018

  • SIPR application
  • Confirmed funding – SIPR and ADPs x 3
  • Post arrangements – University (2 schools),

honorary NHS

  • Ethics application
  • NHS Tayside Research and Development . . .
slide-10
SLIDE 10

Purpose

Produce recommendations that assist the police and partners to align prevention and intervention activities to achieve real world impact in reducing adverse outcomes of substance misuse, specifically rates of drug deaths.

slide-11
SLIDE 11

With many thanks to…

  • Jerusha Vithiyanandan
  • Dr Phyllis Easton
  • Dr Fiona Cowden
  • Dr Vered Hopkins,
  • Superintendent John Wyllie
  • Professor Nick Fyfe